The Advisor

April 20, 2018

Accompass welcomes Carmen Valente to the Business Development team

 

Read More

RECEIVE THE ADVISOR

January 19, 2017

Ontario Broader Public Sector executive compensation framework workshop February 23

Read More
December 12, 2016

Inflectra being approved for Crohn's Disease and Colitis under provincial plans

Pfizer's Inflectra, a subsequent entry biologic drug for indications similar to those for Remicade, has recently been approved for new starts for such indications as Crohn's Disease and Ulcerative Colitis in several provinces, with the other...

Read More
December 12, 2016

Accompass sponsoring Dr. Danielle Martin's January 26 book launch

Read More